Disease states and changes in drug pharmacokinetics;Variazioni della cinetica dei farmaci in condizioni patologiche

Clinica Terapeutica

Volumn 147, Issue 3, 1996, Pages 131-144

  Ventresca, Gian Pietro ^a   Mariani, Luigi ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

UNINDEXED DRUG;

ANIMAL EXPERIMENT; DISEASE COURSE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; HEART FAILURE; HUMAN; KIDNEY FAILURE; LIVER FAILURE; NONHUMAN; PHARMACOKINETICS; REVIEW;

HEART DISEASES; HUMANS; KIDNEY DISEASES; LIVER DISEASES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 0029820955     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Balant L.: Pharmacocinetique. In Fare J., Balan L., Perrier C., Weber I. (Eds.): Thérapeutique medicale. Flammarion Médecine-Sciences 1989; chap. 6-7, 31-43.
2. Bass N.M. e Williams R.L.: Guide to drug dosage in hepatic disease. Clin. Pharmacokinet. 15: 396-420, 1988.
3. Bennett W.M.: Guide to drug dosage in renal failure. Clin.Pharmacokinet. 15: 326-354, 1988.
4. Blaschkle T.F., Meffin P.J., Melmon K.L. e Rowlan M.: Influence of acute viral hepatitis on phenytoin kinetics and protein binding. Ther. 17:685-691, 1975.
5. Branch R.A., James J. e Read A.E.J.: A study of factors influencing drug disposition in chronic liver disease using the model drug (+)-propanolol. Br. J. Clin. Pharmacol. 3: 243-249, 1976.
6. Brodgen R.N., Todd P.A. e Sorkin E.M.: Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 36: 540-600, 1988.
7. Danan G., Montay G., Cunci R. e Erlinger S.: Pefloxacin kinetics in cirrhosis. Clin. Pharmacol. Then 38:439-442, 1985.
8. Dayer P. e Balant L.: Insuffisance hépatique et pharmacodnetique. Méd et Hyg. 38:990-1001, 1980.
9. Dettli L.: Drug dosage in renal disease. Clin. Pharmacokin. 1: 126-134, 1976.
10. Evans. E.E, Proctor J.D., Melvin J.E, Velandia F. e Wasserman A.J.: Blood flow in muscle groups and drug absorption. Clin. Pharmacol. Therap. 17: 44-47, 1975.
11. Gigler G. e Azarnoff D.L.: Drug protein binding and the nephrotic syndrome. Clin Pharmacokin. 1: 25-35, 1976.
12. Hoffler D. e Koeppe P.: Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function. Drugs 34 (Suppl. 1): 51-55, 1987.
13. Klotz U., McHorse T.W., Wilkenson G.R. e Schenker S.: The effect of cirrhosis on the disposition and elimination of meperidine (pethidine) in man. Clin. Pharmacol. Ther. 16: 667-675, 1974.
14. Klotz U., Avant G.R., Hoyumpa A., Schenker S. e Wilkenson G.R.: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J.Clin.Invest. 55: 347-359, 1975.
15. Koup R.J.: Disease states and drug pharmacokinetics. J Clin Pharmacol. 29: 674-679, 1989.
16. Mariani L.: Come la situazione clinica generale può variare la cinetica e la biodisponibilità dei farmaci. In Cardiologia 1984 Edizioni Librex.
17. Nies A.S., Shand D.G. e Wilkinson G.R.: Alterated hepatic blood flow and drug disposition. Clin. Pharmacokin. 1: 135-155, 1976.
18. Parsons PL.: Drug absorption in gastrointestinal disease. Clin Pharmacokin. 2: 45-60, 1977.
19. Piafsky K.M.: Disease induced changes in the plasma binding of basic drugs. Clin. Pharmacokin. 5: 246-262, 1980.
20. Shammas F.V. e Dickstein K.: Clinical pharmacokinetics in heart failure. An updated review. Clin. Pharmacokin. 15:94-113, 1988.
21. Souich P, Melean A.J., Lalka D., Erill S. e Gibaldi M.: Pulmonary disease and drug kinetics. Clin Pharmacokin. 3: 257-266, 1978.
22. Stenson. R.E., Costantino R.T. e Harrison D.C.J.: Interrelationships of hepatic blood flow, cardiac output and blood levels of lidocaine in man. Circulation 43: 205-211, 1971.
23. Thomson. P.D., Melmon K.L., Richardson J.A., Cohn K., Steinbrunn W., Cudihee R. e Rowland M.: Lidocaine pharmacokinetics in advanced heart failure, liver disease and renal failure in humans. Ann. Intern. Med. 78: 499-508, 1973.
24. Vanni R.: Effect of cardiovascular disease on pharmacokinetics. Card. Drugs Ther. 3:711-730, 1989.
25. Williams R.L.: Influenza della malattia epatica sul metabolismo dei farmaci. Rass. Clin. Sci. 61: 206-209, 1985.